Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tectonic Therapeutic (TECX) Income from Continuing Operations (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Income from Continuing Operations data on record, last reported at 25128000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 58.3% to 25128000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 10223000.0, a 81.79% increase, with the full-year FY2025 number at 1001000.0, up 98.2% from a year prior.
  • Income from Continuing Operations reached 25128000.0 in Q1 2026 per TECX's latest filing, down from 53924000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for TECX hit a ceiling of 53924000.0 in Q4 2025 and a floor of 29833000.0 in Q1 2022.
  • A 5-year average of 14095705.88 and a median of 17717000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 76.24% in 2024, then skyrocketed 646.12% in 2025.
  • Tracing TECX's Income from Continuing Operations over 5 years: stood at 25012000.0 in 2022, then skyrocketed by 62.92% to 9275000.0 in 2023, then fell by 6.46% to 9874000.0 in 2024, then surged by 646.12% to 53924000.0 in 2025, then crashed by 146.6% to 25128000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for TECX at 25128000.0 in Q1 2026, 53924000.0 in Q4 2025, and 19035000.0 in Q3 2025.